Index of /content/mda/en/newsroom/2022/06/ibrutinib-with-chemoimmunotherapy-improved-progression-free-survival-for-newly-diagnosed-mantle-cell-lymphoma-patients/jcr_content/
Name | Last Modified | Size |
---|---|---|
2025-05-28 19:07 | - |
Name | Last Modified | Size |
---|---|---|
2025-05-28 19:07 | - |